PhD in Pharmaceutical Outcomes Research and Policy

Application deadline: December 31st

The University of Washington created the Pharmaceutical Outcomes Research and Policy Program (PORPP) in 1995 to strengthen research efforts and provide graduate-level training in the outcomes research and policy areas. In the summer of 2017 PORPP was approved to transition to The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute. An Institute designation better reflects the breadth of work conducted by our faculty, students, and post-docs. It promotes our recognition as an international hub of excellence in the areas of health outcomes research, pharmacoepidemiology, health economics, and policy.

CHOICE faculty, post-doctoral fellows and students conduct analyses of the comparative effectiveness, safety and cost-effectiveness of healthcare interventions to estimate value propositions and improve decision making by patients, clinicians, and policy makers.

Pharmaceutical outcomes research employs a variety of methods to evaluate the impact of healthcare interventions on clinical outcomes, patient quality of life, cost-effectiveness and assessment of healthcare policy implications. The graduate program in pharmaceutical outcomes research and policy trains students in economic evaluation, pharmacoepidemiology, health services and policy research and health technology assessment.

Graduate training in the program prepares students for career opportunities in:

  • Academic research and teaching
  • Pharmaceutical, biotechnology and medical device industries
  • Professional associations, health care insurance providers, and governmental agencies
  • Health-systems and managed care organizations

CHOICE Student Handbook (PDF)
The University of Washington Department of Pharmacy offers graduate training leading to the Ph.D. degree in Pharmaceutical Outcomes Research and Policy. The graduate program includes preparation in the academic disciplines essential to the comparative evaluation of medical interventions on health outcomes, safety and effectiveness; provision of estimates of economic value; and the applications of these to health policy.

Students complete courses in the fields of biostatistics, clinical trial design and analysis, health economics, epidemiology and health policy in order to gain an in-depth understanding of the complex and interdisciplinary environment of outcomes research. Didactic preparation is augmented with substantive involvement in the research and teaching programs of the graduate faculty.

A professional degree in pharmacy, medicine, or a health-related discipline is encouraged. Students with baccalaureate or masters degrees in related fields such as epidemiology, economics, or public health are also encouraged to apply.

Other prerequisites include admission to the Graduate School of the University of Washington, and a minimum grade point average of 3.0. The Graduate Record Examination is required, special weight is given to exceptional scores on the quantitative and analytical portions. Where appropriate, foreign students should present results indicative of proficiency in the English language on the Test of English as a Foreign Language (TOEFL).